Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
13.2M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
1.55M
-
Shares change
-
+1.14M
-
Total reported value, excl. options
-
$1.07M
-
Value change
-
+$796K
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$0.69
Significant Holders of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) as of Q3 2025
19 filings reported holding SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share as of Q3 2025.
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.55M shares
of 13.2M outstanding shares and own 11.73% of the company stock.
Largest 10 shareholders include Anson Funds Management LP (952K shares), AdvisorShares Investments LLC (365K shares), Virtu Financial LLC (108K shares), GEODE CAPITAL MANAGEMENT, LLC (39.6K shares), JANE STREET GROUP, LLC (16.8K shares), TWO SIGMA SECURITIES, LLC (16.5K shares), VANGUARD GROUP INC (16.3K shares), StoneX Group Inc. (13.4K shares), STATE STREET CORP (12.5K shares), and UBS Group AG (8.98K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.